JHU-083
JHU-083 is a prodrug that is currently being researched for its potential therapeutic applications in the treatment of cancer and neurological disorders. It is a derivative of donor methionine, an essential amino acid, and is designed to inhibit the activity of methionine aminopeptidase 2 (MetAP2), an enzyme that plays a crucial role in the growth and proliferation of cancer cells.
Mechanism of Action[edit | edit source]
JHU-083 works by inhibiting the activity of MetAP2, an enzyme that is overexpressed in many types of cancer cells. This enzyme is responsible for removing the methionine residue from the N-terminus of newly synthesized proteins, a process that is essential for protein function and cell viability. By inhibiting MetAP2, JHU-083 disrupts protein synthesis and induces cell death in cancer cells.
Therapeutic Applications[edit | edit source]
Cancer[edit | edit source]
JHU-083 is being investigated for its potential use in the treatment of various types of cancer. Preclinical studies have shown that it can inhibit the growth of cancer cells and induce apoptosis, or programmed cell death. It has also been found to enhance the efficacy of other anticancer drugs, suggesting that it could be used in combination therapies.
Neurological Disorders[edit | edit source]
In addition to its anticancer properties, JHU-083 is also being studied for its potential applications in the treatment of neurological disorders. It has been found to have neuroprotective effects in animal models of neurodegenerative diseases, such as Alzheimer's disease and Parkinson's disease. It is thought to exert these effects by modulating the activity of glutamate, a neurotransmitter that plays a key role in neuronal function and survival.
Safety and Tolerability[edit | edit source]
The safety and tolerability of JHU-083 are currently being evaluated in clinical trials. So far, it has been found to be well-tolerated in animal models, with no significant adverse effects reported.
See Also[edit | edit source]
- Prodrug
- Cancer
- Neurological disorders
- Methionine aminopeptidase 2
- Apoptosis
- Neurodegenerative diseases
- Alzheimer's disease
- Parkinson's disease
- Glutamate
 | This pharmacology-related article is a stub. You can help WikiMD by expanding it. |
Search WikiMD
Ad.Tired of being Overweight? Try W8MD's physician weight loss program.
Semaglutide (Ozempic / Wegovy and Tirzepatide (Mounjaro / Zepbound) available.
Advertise on WikiMD
|
WikiMD's Wellness Encyclopedia |
| Let Food Be Thy Medicine Medicine Thy Food - Hippocrates |
Translate this page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian
Medical Disclaimer: WikiMD is not a substitute for professional medical advice. The information on WikiMD is provided as an information resource only, may be incorrect, outdated or misleading, and is not to be used or relied on for any diagnostic or treatment purposes. Please consult your health care provider before making any healthcare decisions or for guidance about a specific medical condition. WikiMD expressly disclaims responsibility, and shall have no liability, for any damages, loss, injury, or liability whatsoever suffered as a result of your reliance on the information contained in this site. By visiting this site you agree to the foregoing terms and conditions, which may from time to time be changed or supplemented by WikiMD. If you do not agree to the foregoing terms and conditions, you should not enter or use this site. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates Wikipedia, licensed under CC BY SA or similar.
Contributors: Prab R. Tumpati, MD
